A PRACTICAL EXPERIENCE OF EFFICIENT USAGE OF CORDAFLEX-RETARD IN OUT-PATIENTS WITH ESSENTIAL HYPERTENSION
We have studied clinical efficacy and safety of a II generation calcium antagonist cordaflex-retard administered in a daily dose of 40 mg for 4 weeks to 40 patients with essential hypertension. Efficacy was estimated by clinical BP measuring and daily monitoring. The results indicate BP decrease in...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2000-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2229 |